Joseph John Mogan Iii is a Metairie, Louisiana based physiatrist who is specialized in Pain Management (PM&R). Active license number of Joseph John Mogan Iii as Pain Management (PM&R) is 022700 in Louisiana.
Joseph John Mogan Iii provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
Complete Profile:
Joseph John Mogan Iii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Pain Management (PM&R)
Credentials:
MD
Gender:
Male
Practice Address:
2701 David Dr Ste A, Metairie, Louisiana, 70003-4511
Phone:
504-455-4949
Fax:
504-455-4145
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1831119684
NPI Enumeration Date:
21 Jul, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Joseph John Mogan Iii are as mentioned below.
License Number
Specialization
State
Status
022700
Pain Management
Louisiana
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Po Box 1725, Kenner, Louisiana
Zip:
70063-1725
Phone Number:
504-469-1960
Fax Number:
504-469-1979
Patients can reach Joseph John Mogan Iii at 2701 David Dr Ste A, Metairie, Louisiana or can call to book an appointment on 504-455-4949. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.